COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,032 Articles (22,627 medRxiv, 8,405 bioRxiv)

Most recent first Previous |  Page 393: Articles 3921-3930  | Next

The Brazilian vaccine divide: how some municipalities are being left behind in the Covid-19 vaccine coverage
Boing, A. F., BOING, A. C., Barberia, L., Borges, M. E., Subramanian, S.
10.1101/2023.05.23.23290401 — Posted: 2023-05-28
Long COVID and financial outcomes: Evidence from four longitudinal population surveys
Rhead, R., Wels, J., Moltrecht, B., Shaw, R. J., Silverwood, R. J., Zhu, J., Hughes, A., Chaturvedi, N., Demou, E., Katikireddi, S. V., Ploubidis, G.
10.1101/2023.05.23.23290354 — Posted: 2023-05-28
Nurses' perceptions of videoconferencing telenursing: comparing frontal learning vs. online learning before and after the COVID-19 pandemic
Kats, S., Shmueli, L.
10.1101/2023.05.22.23290291 — Posted: 2023-05-28
Researching COVID to enhance recovery (RECOVER) adult study protocol: Rationale, objectives and design
Horwitz, L. I., Thaweethai, T., Brosnahan, S. B., Cicek, M. S., Fitzgerald, M. L., Goldman, J. D., Hess, R., Hodder, S. L., Jacoby, V. L., Jordan, M. R., Krishnan, J. A., Laiyemo, A. O., Metz, T. D., Nichols, L., Patzer, R. E., Sekar, A., Singer, N. G., Stiles, L. E., Taylor, B. S., Ahmed, S., Algren, H. A., Anglin, K., Aponte-Soto, L., Ashktorab, H., Bassett, I. V., Bedi, B., Bhadelia, N., Bime, C., Bind, M.-A. C., Black, L. J., Blomkalns, A. L., Brim, H., Castro, M., Chan, J., Charney, A. W., Chen, B. K., Chen, L. Q., Chen, P., Chestek, D., Chibnik, L. B., Chow, D. C., Chu, H. Y., Clifton, R
10.1101/2023.05.26.23290475 — Posted: 2023-05-28
Missing data and missed infections: Investigating racial and ethnic disparities in SARS-CoV-2 testing and infection rates in Holyoke, Massachusetts
Sauer, S. M., Fulcher, I. R., Matias, W. R., Paxton, R., Elnaiem, A., Gonsalves, S., Zhu, J., Guillaume, Y., Franke, M. F., Ivers, L. C.
10.1101/2023.05.24.23290470 — Posted: 2023-05-28
Analysing the psychosocial and health impacts of Long COVID in Pakistan: A cross sectional study
Khan, M., Majeed, S., Ain, Q., Nawaz, A., Sumra, K. A., Lammi, V., Nihal, F., Afrah, A., Khan, E. A., Khan, M. I., Sadiq, F.
10.1101/2023.05.22.23290323 — Posted: 2023-05-28
A patient-centered view of symptoms, functional impact, and priorities in post-COVID-19 syndrome: Cross-sectional results from the Quebec Action Post-COVID cohort
Mayo, N. E., Brouillette, M.-J., Falcone, E. L., Fellows, L.
10.1101/2023.05.27.23290638 — Posted: 2023-05-28
Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Pharmacy Model of Care
Ghazzawi, M., Babawo, L. S., Mohareb, A. M., James, P. B., Yendewa, S. A., Massaquoi, S. P., Cummings, P. E., Lakoh, S., Salata, R. A., Yendewa, G. A.
10.1101/2023.05.24.23290418 — Posted: 2023-05-28
Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong
KWOK, K. O., WEI, W. I., MCNEIL, E., TANG, A., TANG, J., WONG, S. Y.-S., YEOH, E. K.
10.1101/2023.05.25.23289996 — Posted: 2023-05-28
A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar
Chemaitelly, H., Ayoub, H. H., Faust, J. S., Coyle, P., Tang, P., Hasan, M. R., YASSINE, H. M., Al-Khatib, H. A., Althani, A. A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2023.05.28.23290641 — Posted: 2023-05-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).